Meeting Details

The 8th Annual General Meeting of Entero Healthcare Solutions Limited was held on Wednesday, August 19, 2026, at 12:30 P.M. (IST) through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM") without physical presence of members. The meeting concluded at 1:25 P.M. (IST).

Mr. Sujesh Vasudevan, Chairman of the Board, chaired the meeting. Ms. Sanu Kapoor, Group General Counsel & Company Secretary, conducted the proceedings and provided statutory instructions to members.

Attendance Details

  • Total shareholders on record date (August 12, 2026): 37,817
  • Promoters and promoter group attendees through VC: 3
  • Public shareholders attendees through VC: 34
  • No shareholders attended in person or through proxy

Voting Process and Scrutinizer Appointment

  • Remote e-voting conducted through NSDL platform from August 16, 2026 (9:00 AM IST) to August 18, 2026 (5:00 PM IST)
  • E-voting facility provided during AGM for members who hadn't voted remotely
  • Mr. Avinash Bagul of M/s. BNP & Associates appointed as Scrutinizer (Board meeting date: May 25, 2026)
  • Scrutinizer's report dated August 19, 2026

Resolutions Considered and Voting Results

All seven resolutions set out in the Notice dated July 17, 2026 were put to vote and passed with requisite majority:

Ordinary Business:

1. Adoption of Audited Standalone Financial Statements for FY26 - Passed with 99.9996% votes in favor (33,286,807 votes for, 127 against)

2. Adoption of Audited Consolidated Financial Statements for FY26 - Passed with 99.9996% votes in favor (33,286,807 votes for, 127 against)

3. Re-appointment of Mr. Arun Sadhanandham (DIN: 08445197) as Non-Executive Non-Independent Director - Passed with 99.9005% votes in favor (33,253,817 votes for, 33,117 against)

Special Business:

4. Payment of Remuneration to Mr. Prabhat Agrawal (DIN: 07466382) as Managing Director & CEO for remaining tenure - Passed with 93.5766% votes in favor (27,379,142 votes for, 1,879,397 against)

5. Payment of Remuneration to Mr. Prem Sethi (DIN: 07077034) as Whole Time Director & COO for remaining tenure - Passed with 93.9466% votes in favor (29,167,695 votes for, 1,879,397 against)

6. Re-appointment of Mr. Sujesh Vasudevan (DIN: 08240092) as Non-Executive Independent Director and payment of remuneration for second term - Passed with 94.3368% votes in favor (31,401,828 votes for, 1,885,106 against)

7. Re-appointment of Ms. Sandhya Gadkari Sharma (DIN: 02005378) as Non-Executive Independent Director and payment of remuneration for second term - Passed with 94.3467% votes in favor (31,405,114 votes for, 1,881,820 against)

Voting Participation Summary

  • Total shares outstanding: 43,523,072
  • Total votes polled: 33,286,934 (76.4811% participation)
  • Promoter & Promoter Group participation: 22,807,166 votes (99.9981% of their holding)
  • Public Institutions participation: 5,419,725 votes (60.5642% of their holding)
  • Public Non-Institutions participation: 5,060,043 votes (43.0029% of their holding)

Meeting Proceedings

The Chairman delivered a speech covering company overview. Mr. Prabhat Agrawal, Managing Director & CEO, addressed members regarding company performance and key developments during the year.

Registered speaker shareholders were invited to express views and ask questions, with queries suitably replied and clarifications provided.

Office Addresses

  • Corporate Office: Entero House, Crystal Plaza - 158, C.S.T. Road, Kalina, Mumbai-400 098, Maharashtra

#Tags: #EnteroHealthcare #AGM #SEBIDisclosure #RegulatoryCompliance #CorporateGovernance #Neutral